Navigation Links
Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan

* New study results show more patients receiving both Tekturna and Diovan reached target blood pressure goal compared to those taking either agent alone

EAST HANOVER, N.J., March 26, 2007 /PRNewswire/ -- Results from a new study have shown patients taking two Novartis cardiovascular medicines -- the recently U.S.-approved drug Tekturna(R) (aliskiren) and the leading therapy Diovan(R) (valsartan) -- experienced greater reductions in blood pressure levels than those using either agent alone.

The study also found more patients receiving both Tekturna, which received U.S. approval in March and represents the first type of new high blood pressure medicine in a decade, and Diovan reached their treatment goal compared to either drug alone (ACC presentation #405).

Data from this trial involving 1,800 patients -- the first large-scale study to assess the potential benefits of combining these medicines -- were presented for the first time at the of Cardiology 56th Scientific Session in New Orleans.

Half of the patients in the eight-week trial taking both Tekturna and Diovan saw a reduction in blood pressure to the target of 140/90 mmHg (systolic/diastolic pressure), higher levels than seen in patients taking either of the medicines alone.

Tekturna and Diovan work in different ways to target the renin angiotensin system, one of the body's key regulators of blood pressure. Tekturna targets renin, an enzyme responsible for triggering a process that can lead to high blood pressure. Diovan, an angiotensin receptor blocker (ARB) and one of the world's most-prescribed cardiovascular medicines, works later in this system by blocking the action of angiotensin II, which causes narrowing of blood vessels.

"These study results are exciting because they suggest the value of different mechanisms of action when Tekturna and Diovan are used together," said Suzanne Oparil, MD, Director of the Vascular B
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:7/30/2014)... WOODCLIFF LAKE, N.J. and SAN DIEGO ... Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today that ... Phase 3 trials of lorcaserin entitled, "Early Weight Loss While ... 52 Weight-Loss Outcomes," was recently published in the online issue ... The Obesity Society. The objective of these analyses was to ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 ... of new products for oncology supportive care, announced that ... has been featured in an article on OncLive.com titled, ... Head and Neck Cancers."  Dr. Steve Sonis , ... the growing demand seen in the oncology community for ...
(Date:7/30/2014)... July 30, 2014 /PRNewswire-iReach/ -- This is a ... Chinese Heparin sodium (CAS 9041-08-1) & calcium (CAS ... information of Heparin sodium (CAS 9041-08-1) & calcium ... technology. The report then explores global and China,s ... calcium (CAS 37270-89-6) listing their product specification, capacity, ...
Breaking Medicine Technology:Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5
(Date:7/31/2014)... 31, 2014 USHIO America’s Solid ... and general lighting marketplaces, today announced the launch ... will allow users to transform existing, inefficient lamp-based ... minutes. , USHIO America’s Uphoria LED downlight retrofit ... cans, allowing the user to upgrade old incandescent ...
(Date:7/31/2014)... Thanks to its mildly sweet ... long been used as a medium for delivery ... fruit. However consistent, dependable sourcing of erythritol often ... food and beverage manufacturers’ increasing needs for reliable, ... GMO-free ErysweetTM Erythritol. , “Erysweet is unique ...
(Date:7/30/2014)... Colorado (PRWEB) July 30, 2014 Vail ... skiers wearing orange vests emblazoned with “Blind Skier.” Those ... slopes through Foresight Ski Guides , a non-profit ... visually impaired and blind participants (VIPs) for snow sport ... in guiding can learn more and pick up an ...
(Date:7/30/2014)... CareSource, a nonprofit, Ohio-based health plan, is pleased ... Credit Union, to the CareSource Ohio Board of Trustees. ... an extensive background in leading credit unions. He was ... officer at Wright-Patt Credit Union (WPCU) in Fairborn, Ohio. ... Union that has realized more than seven years of ...
(Date:7/30/2014)... events experienced during deployment, returning National Guard soldiers ... if faced with civilian life setbacks, including job ... legal problemsall commonplace in military families. Results of ... School of Public Health are published online in ... , Alcohol abuse is a major concern for ...
Breaking Medicine News(10 mins):Health News:USHIO America Introduces Uphoria™ LED Downlight Retrofit Kits 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Colorado Non-Profit Foresight Ski Guides Seeking Applications for Blind and Visually Impaired Skiers and Guides for Vail Ski Season 2Health News:Vets' alcohol problems linked to stress on the home front 2
... May 11 (HealthDay News) -- Retrieving about 15 eggs from ... cycle offers the best chance of achieving a live birth ... study. Researchers analyzed more than 400,000 IVF cycles in ... strong association between live birth rates and the number of ...
... HealthDay Reporter , TUESDAY, May 10 (HealthDay News) -- ... may lower their risk for developing a particular type of ... of five or more cups of coffee a day to ... ER-negative breast cancer. However, coffee consumption did not appear ...
... 11, 2011Most Maryland residents trust the health and medical ... magazines (68%), radio (66%)and the Internet (also 66%), according ... media fared less well, with 51% saying social media ... Fewer than 20% use their cell phone or other ...
... one day take rides on starch compounds creating ... to Penn State food scientists. The technique may ... more environmentally friendly alternative in creating, among other ... of experiments, researchers formed pockets with corn starch ...
... useful would it be to anticipate how well someone will ... be able to stay calm during stress? To ... of psychology at Case Western Reserve University, finds clues in ... with regard to how well they can control their emotions, ...
... are told, heightens our senses, imprinting sights and sounds ... which appeared in Nature Neuroscience this week, ... learned in an aversive context are not as sharp ... hint that this tendency is rooted in our species, ...
Cached Medicine News:Health News:Number of Eggs Retrieved Helps Predict IVF Success: Study 2Health News:Are Coffee Drinkers Less Prone to Aggressive Breast Cancer? 2Health News:Are Coffee Drinkers Less Prone to Aggressive Breast Cancer? 3Health News:Maryland poll: Traditional media and internet more trusted than social media for research news 2Health News:Maryland poll: Traditional media and internet more trusted than social media for research news 3Health News:Vitamins may hitch a protected ride on corn starch 2Health News:When words get hot, mental multitaskers collect cool 2Health News:When words get hot, mental multitaskers collect cool 3Health News:Weizmann Institute scientists show: How adversity dulls our perceptions 2
... The SR™ Hand Implant System utilizes ... and knee joint replacements. The SR™ ... available in other prostheses including minimal bone ... eroded cartilaginous articular surfaces, retention and/or repositioning ...
For use in implant resection arthroplasty of the trapeziometacarpal joint in cases of rheumatoid, degenerative or post-traumatic arthritis....
The efficient choice for small joint replacement technology -- the Ascension Silicone MCP features a similar design to our PyroCarbon MCP and utilizes the same instrumentation for intra-operative fle...
... Hand Implant System utilizes the same proven ... replacements. The SR™ Hand Implant System ... prostheses including minimal bone resection, surface replacement ... surfaces, retention and/or repositioning of the ligamentous ...
Medicine Products: